Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03119259 · ClinicalTrials.gov registry record · NA
Technology Intervention to Support Caregiving for Alzheimer's Disease (I-CARE)
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT03119259: Completed NA study, sponsored by Indiana University.
NCT03119259 is a NA study that has completed, run by Indiana University. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03119259, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The specific aims of this study are 1) to test the trial and intervention feasibility of Brain Care Notes (BCN) app, 2) To estimate the effect size of BCN on reducing informal caregiver burden at 6 months, and 3) To estimate the effect size of BCN on reducing patient behavioral and psychological symptoms of dementia (BPSD) at 6 months. Subjects will be recruited from the Aging Brain Care (ABC) program of Eskenazi Health and Indiana University Health located in central Indiana.
Primary Outcome
Recruitment rate is the average monthly rate of recruitment into the study, calculated as participants recruited over the accrual period.
Interventions
- BEHAVIORAL ABC Clinical Program
- BEHAVIORAL BCN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2019-11-25 |
| Est. Completion | 2021-07-31 |
| Phase | NA |
What the finished NCT03119259 record still lists
NCT03119259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which ABC Clinical Program is the first listed.
NCT03119259 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03119259 about?
NCT03119259 is a clinical study titled "Technology Intervention to Support Caregiving for Alzheimer's Disease (I-CARE)". The specific aims of this study are 1) to test the trial and intervention feasibility of Brain Care Notes (BCN) app, 2) To estimate the effect size of BCN on reducing informal caregiver burden at 6 months, and 3) To estimate the effect size of BCN on reducing patient behavioral and psychological sym...
What is the current status of trial NCT03119259?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2019-11-25. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT03119259?
The interventions under investigation include: ABC Clinical Program (BEHAVIORAL), BCN (BEHAVIORAL).
Who is sponsoring clinical trial NCT03119259?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03119259's enrollment target sits among peer trials
53 1271st of 2000 higher than 729 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI